FindTrial
Sign In

Study on the mechanism of expression and invasion of DAB2IP in cutaneous squamous cell carcinoma

Study on the mechanism of expression and invasion of DAB2IP in cutaneous squamous cell carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000038327
Enrollment
Unknown
Registered
2020-09-18
Start date
2019-01-01
Completion date
Unknown
Last updated
2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cutaneous squamous cell carcinoma

Interventions

cSCC group:N/A
control group:N/A

Sponsors

Guangdong Second Provincial General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
26 Years to 91 Years

Inclusion criteria

Inclusion criteria: Patients who suffer from CSCC.

Exclusion criteria

Exclusion criteria: 1. Patients who have undergone gene therapy, radiotherapy, or chemotherapy or immunotherapy; 2. Patients who suffer from other skin desease at the same time.

Design outcomes

Primary

MeasureTime frame
Immunohistochemistry ;—

Countries

China

Contacts

Public ContactWen Ju

Guangdong Second Provincial General Hospital

wenju3139@163.com+86 13829764166

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026